Could the Next Anti-Aging Breakthrough Come From the Ocean?

Southern Cross University’s Dr. Nedeljka Rosic highlights marine ecosystems as a promising source of bioactive compounds for anti-aging therapies, citing algae-derived antioxidants and unique metabolites that target oxidative stress and telomere integrity. Her research emphasizes the sustainability, scalability, and multi-functional bioactivity of marine-derived ingredients, including their potential to modulate aging through the redox-telomere-antioncogene axis and enhance antioxidant defenses via algal polysaccharides.
Southern Cross University’s Dr. Nedeljka Rosic argues that marine ecosystems could hold the key to breakthroughs in anti-aging therapies. Her research focuses on marine natural products—compounds derived from organisms like sponges, algae, tunicates, and marine bacteria—which exhibit diverse biological activities, including anti-aging, UV protection, anti-inflammatory, and anticancer properties. Marine environments, particularly algae-rich systems, offer significant advantages over traditional sources. Rosic notes that sourcing bioactive compounds from macroalgae and microalgae supports sustainable, low-carbon production while enabling cost-effective and scalable manufacturing. These compounds also provide multi-functional benefits, making them attractive for pharmaceuticals, cosmetics, and nutraceuticals. The anti-aging effects of marine-derived compounds operate through interconnected cellular pathways. Rosic highlights the redox-telomere-antioncogene axis, where polyunsaturated fatty acids (PUFAs) help maintain redox balance, reduce oxidative stress, and limit telomere shortening—key factors in aging. Marine algal polysaccharides (MAPs) further enhance endogenous antioxidant defenses by upregulating the gene expression of antioxidant enzymes. Rosic’s work underscores the potential of marine bioactives to address multiple aging-related mechanisms. By targeting oxidative stress, immune function, and metabolism, these compounds could offer a novel approach to developing safe and effective anti-aging interventions. However, translational barriers—such as optimizing extraction and clinical validation—must be overcome to bring these molecules into commercial and clinical use.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.